HEADER COMPLEMENT INHIBITOR 25-JUL-00 1E5G TITLE SOLUTION STRUCTURE OF CENTRAL CP MODULE PAIR OF A POX VIRUS TITLE 2 COMPLEMENT INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: COMPLEMENT CONTROL PROTEIN C3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: MODULES 2 AND 3 RESIDUES 84-203; COMPND 5 SYNONYM: SP35,28 KDA PROTEIN, SECRETORY PROTEIN 35, PROTEIN C3, VCP; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: VACCINIA VIRUS; SOURCE 3 ORGANISM_TAXID: 10249; SOURCE 4 STRAIN: COPENHAGEN; SOURCE 5 GENE: C21L; SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: KM71; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPICZALPHAA WITHOUT HISTIDINE DEFICIENCY KEYWDS COMPLEMENT INHIBITOR EXPDTA SOLUTION NMR NUMMDL 50 AUTHOR C.E.HENDERSON,K.BROMEK,N.P.MULLIN,B.O.SMITH,D.UHRIN,P.N.BARLOW REVDAT 4 03-JUL-13 1E5G 1 COMPND SOURCE KEYWDS AUTHOR REVDAT 4 2 JRNL REMARK VERSN DBREF REVDAT 4 3 SHEET ATOM TER MASTER REVDAT 4 4 CONECT REVDAT 3 24-FEB-09 1E5G 1 VERSN REVDAT 2 26-APR-01 1E5G 1 JRNL REVDAT 1 31-AUG-00 1E5G 0 JRNL AUTH C.E.HENDERSON,K.BROMEK,N.P.MULLIN,B.O.SMITH,D.UHRIN, JRNL AUTH 2 P.N.BARLOW JRNL TITL SOLUTION STRUCTURE AND DYNAMICS OF THE CENTRAL CCP MODULE JRNL TITL 2 PAIR OF A POXVIRUS COMPLEMENT CONTROL PROTEIN JRNL REF J.MOL.BIOL. V. 307 323 2001 JRNL REFN ISSN 0022-2836 JRNL PMID 11243823 JRNL DOI 10.1006/JMBI.2000.4477 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN REMARK 3 THE JRNL CITATION REMARK 4 REMARK 4 1E5G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-JUL-00. REMARK 100 THE PDBE ID CODE IS EBI-5177. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 310 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY,COSY,TOCSY, REMARK 210 3D HSQC NOESY, TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR REMARK 210 METHOD USED : ARIA REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 50 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 37 REMARK 210 REMARK 210 REMARK: 15N-LABELLED VCP MODULES 2 AND 3 WAS USED TO OBTAIN REMARK 210 HSQC NOESY AND TOCSY EXPERIMENTS TO ASSIGN THE BACKBONE REMARK 210 ATOMS. 2D EXPERIMENTS WERE THEN USED IN CONJUNCTION WITH REMARK 210 THE 3D TECHNIQUES TO ASSIGN THE SIDE CHAIN ATOMS AND THE REMARK 210 STRUCTURE WAS CALCULATED USING UNAMBIGUOUS AND AMBIGUOUS REMARK 210 RESTRAINTS REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 FUNCTION: SERVES TO PROTECT THE VIRUS AGAINST COMPLEMENT ATTACK BY REMARK 400 INHIBITING BOTH CLASSICAL AND ALTERNATIVE PATHWAYS OF COMPLEMENT REMARK 400 ACTIVATION. BINDS C3B AND C4B. REMARK 400 SIMILARITY: BELONGS TO THE SUPERFAMILY OF THE REGULATORS OF REMARK 400 COMPLEMENT ACTIVATION (RCA). REMARK 400 SIMILARITY: CONTAINS 4 SUSHI (SCR) REPEATS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TYR A 48 H ASN A 60 1.57 REMARK 500 H ILE A 106 O THR A 123 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ARG A 8 166.70 54.98 REMARK 500 1 SER A 11 104.38 -48.77 REMARK 500 1 PRO A 12 156.92 -49.95 REMARK 500 1 ASN A 17 29.80 39.01 REMARK 500 1 ILE A 22 93.44 -69.81 REMARK 500 1 PHE A 27 97.15 -49.98 REMARK 500 1 ASN A 36 -84.77 -68.25 REMARK 500 1 SER A 45 18.78 -157.38 REMARK 500 1 PRO A 61 96.10 -17.21 REMARK 500 1 GLU A 62 -77.32 -93.94 REMARK 500 1 PRO A 64 -154.81 -86.01 REMARK 500 1 VAL A 69 100.61 -45.79 REMARK 500 1 GLN A 72 -163.83 -70.22 REMARK 500 1 PRO A 75 161.06 -39.71 REMARK 500 1 ASN A 83 -87.84 -104.53 REMARK 500 1 ASP A 91 94.36 -50.51 REMARK 500 1 ASN A 100 -85.89 -98.30 REMARK 500 1 ASP A 120 46.65 70.67 REMARK 500 2 SER A 11 104.30 -48.59 REMARK 500 2 PRO A 12 167.37 -43.09 REMARK 500 2 ASN A 17 45.47 -90.52 REMARK 500 2 ASN A 36 -81.51 -61.70 REMARK 500 2 SER A 37 117.47 -163.60 REMARK 500 2 SER A 45 23.81 -163.15 REMARK 500 2 PRO A 61 101.57 -16.21 REMARK 500 2 GLU A 62 -69.40 -97.88 REMARK 500 2 ALA A 63 76.02 -102.85 REMARK 500 2 PRO A 64 -152.40 -56.90 REMARK 500 2 VAL A 69 101.57 -47.90 REMARK 500 2 GLN A 72 -174.94 -68.61 REMARK 500 2 PRO A 74 -178.62 -37.48 REMARK 500 2 PRO A 75 -166.44 -68.47 REMARK 500 2 ILE A 77 -159.05 -107.75 REMARK 500 2 ASN A 83 -68.70 -123.61 REMARK 500 2 ASP A 91 95.53 -57.54 REMARK 500 2 ASN A 100 -85.47 -56.24 REMARK 500 2 TYR A 103 -171.69 -68.57 REMARK 500 2 LEU A 105 102.99 -49.03 REMARK 500 3 ARG A 13 173.45 -57.88 REMARK 500 3 ASN A 17 40.78 -93.65 REMARK 500 3 ASN A 36 -84.34 -65.30 REMARK 500 3 SER A 45 19.11 -156.40 REMARK 500 3 CYS A 49 80.84 -68.72 REMARK 500 3 THR A 54 33.41 -98.07 REMARK 500 3 PRO A 61 104.29 -18.00 REMARK 500 3 GLU A 62 -81.52 -106.92 REMARK 500 3 PRO A 64 -155.45 -91.52 REMARK 500 3 VAL A 69 97.05 -48.58 REMARK 500 3 GLN A 72 -157.68 -70.81 REMARK 500 3 PRO A 75 157.32 -44.03 REMARK 500 REMARK 500 THIS ENTRY HAS 991 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 2 PRO A 74 -12.04 REMARK 500 27 PRO A 74 -12.12 REMARK 500 47 PRO A 74 -12.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1VVC RELATED DB: PDB REMARK 900 C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL REMARK 900 PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1VVD RELATED DB: PDB REMARK 900 C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL REMARK 900 PROTEIN, NMR, 21 STRUCTURES REMARK 900 RELATED ID: 1VVE RELATED DB: PDB REMARK 900 C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL REMARK 900 PROTEIN, NMR, 21 STRUCTURES DBREF 1E5G A 7 126 UNP P68639 VCP_VACCC 84 203 SEQRES 1 A 120 ARG ARG CYS PRO SER PRO ARG ASP ILE ASP ASN GLY GLN SEQRES 2 A 120 LEU ASP ILE GLY GLY VAL ASP PHE GLY SER SER ILE THR SEQRES 3 A 120 TYR SER CYS ASN SER GLY TYR HIS LEU ILE GLY GLU SER SEQRES 4 A 120 LYS SER TYR CYS GLU LEU GLY SER THR GLY SER MET VAL SEQRES 5 A 120 TRP ASN PRO GLU ALA PRO ILE CYS GLU SER VAL LYS CYS SEQRES 6 A 120 GLN SER PRO PRO SER ILE SER ASN GLY ARG HIS ASN GLY SEQRES 7 A 120 TYR GLU ASP PHE TYR THR ASP GLY SER VAL VAL THR TYR SEQRES 8 A 120 SER CYS ASN SER GLY TYR SER LEU ILE GLY ASN SER GLY SEQRES 9 A 120 VAL LEU CYS SER GLY GLY GLU TRP SER ASP PRO PRO THR SEQRES 10 A 120 CYS GLN ILE SHEET 1 AA 4 GLY A 18 ILE A 22 0 SHEET 2 AA 4 SER A 30 CYS A 35 -1 O THR A 32 N ASP A 21 SHEET 3 AA 4 LYS A 46 LEU A 51 -1 O SER A 47 N ILE A 31 SHEET 4 AA 4 MET A 57 TRP A 59 -1 O VAL A 58 N GLU A 50 SHEET 1 AB 2 TYR A 39 HIS A 40 0 SHEET 2 AB 2 GLU A 67 SER A 68 -1 O GLU A 67 N HIS A 40 SHEET 1 AC 2 CYS A 71 GLN A 72 0 SHEET 2 AC 2 PHE A 88 TYR A 89 -1 O TYR A 89 N CYS A 71 SHEET 1 AD 4 GLY A 80 HIS A 82 0 SHEET 2 AD 4 SER A 93 CYS A 99 -1 O SER A 98 N ARG A 81 SHEET 3 AD 4 GLY A 110 CYS A 113 -1 O VAL A 111 N VAL A 95 SHEET 4 AD 4 TRP A 118 SER A 119 -1 O SER A 119 N LEU A 112 SHEET 1 AE 2 SER A 104 ILE A 106 0 SHEET 2 AE 2 THR A 123 GLN A 125 -1 O THR A 123 N ILE A 106 SSBOND 1 CYS A 9 CYS A 49 1555 1555 2.18 SSBOND 2 CYS A 35 CYS A 66 1555 1555 2.10 SSBOND 3 CYS A 71 CYS A 113 1555 1555 2.20 SSBOND 4 CYS A 99 CYS A 124 1555 1555 2.19 CISPEP 1 PRO A 74 PRO A 75 2 -18.85 CISPEP 2 ASN A 60 PRO A 61 5 -0.02 CISPEP 3 ASN A 60 PRO A 61 6 1.44 CISPEP 4 ALA A 63 PRO A 64 6 12.30 CISPEP 5 ASN A 60 PRO A 61 9 1.09 CISPEP 6 ALA A 63 PRO A 64 10 16.21 CISPEP 7 ALA A 63 PRO A 64 12 19.14 CISPEP 8 ASN A 60 PRO A 61 14 -0.74 CISPEP 9 ASN A 60 PRO A 61 15 -0.90 CISPEP 10 ASN A 60 PRO A 61 17 2.08 CISPEP 11 ASP A 120 PRO A 121 19 -17.35 CISPEP 12 ASN A 60 PRO A 61 23 -0.98 CISPEP 13 ASN A 60 PRO A 61 26 -0.31 CISPEP 14 PRO A 74 PRO A 75 27 -18.85 CISPEP 15 ASP A 120 PRO A 121 34 -14.08 CISPEP 16 ASN A 60 PRO A 61 40 1.79 CISPEP 17 ASN A 60 PRO A 61 41 1.36 CISPEP 18 ASP A 120 PRO A 121 42 -21.24 CISPEP 19 ASN A 60 PRO A 61 43 -0.34 CISPEP 20 ASN A 60 PRO A 61 44 0.01 CISPEP 21 ASN A 60 PRO A 61 45 -0.52 CISPEP 22 PRO A 74 PRO A 75 47 -19.26 CISPEP 23 ASN A 60 PRO A 61 48 -0.65 CISPEP 24 ALA A 63 PRO A 64 49 15.44 CISPEP 25 SER A 11 PRO A 12 50 -0.97 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1